| scholarly article | Q13442814 |
| P50 | author | Lewis Kuller | Q88077314 |
| Philip Greenland | Q93019727 | ||
| Colby R Ayers | Q114308477 | ||
| Jarett D Berry | Q114414590 | ||
| Charles B Eaton | Q40142297 | ||
| Donald Lloyd-Jones | Q47321195 | ||
| P2093 | author name string | John S Gottdiener | |
| Liviu Klein | |||
| Ambarish Pandey | |||
| Norrina B Allen | |||
| Wally Omar | |||
| Michael LaMonte | |||
| P2860 | cites work | Epidemiology of heart failure with preserved ejection fraction | Q85316469 |
| Sedentary Lifestyle and the Risk for HFpEF: Are "Huff-Puff Health Clubs" the Answer? | Q89396841 | ||
| 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines | Q26864648 | ||
| Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 | ||
| Outcome of heart failure with preserved ejection fraction in a population-based study | Q28252947 | ||
| The Cardiovascular Health Study: design and rationale | Q29614874 | ||
| Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
| Epidemiology of heart failure with preserved ejection fraction | Q30234501 | ||
| Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
| Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). | Q33682532 | ||
| Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). | Q33685255 | ||
| A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. | Q35672064 | ||
| Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). | Q35690501 | ||
| Lifetime risks of cardiovascular disease | Q35913358 | ||
| Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project | Q36745403 | ||
| Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes | Q36992652 | ||
| Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction | Q36993734 | ||
| Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. | Q37058596 | ||
| Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis). | Q37207790 | ||
| Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial | Q37417004 | ||
| Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women | Q38387058 | ||
| Low Fitness in Midlife: A Novel Therapeutic Target for Heart Failure with Preserved Ejection Fraction Prevention | Q38485814 | ||
| Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. | Q38496638 | ||
| Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease | Q40127629 | ||
| Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction | Q40224663 | ||
| Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study | Q40296294 | ||
| Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. | Q45178052 | ||
| Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry | Q46135201 | ||
| Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database | Q46874074 | ||
| Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes | Q47731353 | ||
| Lifetime Risk for Developing Congestive Heart Failure | Q57073232 | ||
| Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study | Q70785076 | ||
| Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study | Q80533387 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| ejection fraction | Q641303 | ||
| Heart failure with preserved ejection fraction | Q3799239 | ||
| heart failure with reduced ejection fraction | Q56218018 | ||
| P304 | page(s) | 1814-1823 | |
| P577 | publication date | 2018-01-19 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction | |
| P478 | volume | 137 |
| Q94582978 | Contemporary use of devices in chronic heart failure in the Netherlands |
| Q96131840 | Epidemiology of heart failure |
| Q96026980 | Healthy lifestyle and risk of incident heart failure with preserved and reduced ejection fraction among post-menopausal women: The women's health initiative study |
| Q92965874 | Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial Substudy |
| Q104503718 | Improving female enrolment in randomized clinical trials of HFrEF to ensure evidence-based health care recommendations |
| Q90482437 | Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling |
| Q57810233 | Post-systolic shortening: normal values and association with validated echocardiographic and invasive measures of cardiac function |
| Q92511093 | Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS |
| Q92543797 | Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies |
| Q92411237 | Sex differences in cardiac function, biomarkers and exercise performance in heart failure with preserved ejection fraction: findings from the RELAX trial |
| Q90706189 | Sex-related differences in contemporary biomarkers for heart failure: a review |
| Q92791950 | The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction |
| Q57171367 | Vitamin D Statusand Exercise Capacity in Older Patients with Heart Failure with Preserved Ejection Fraction |
Search more.